Central Pharmaceutical Joint Stock Company No3 reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported revenue was VND 126,702.51 million compared to VND 97,673.07 million a year ago. Net income was VND 22,157.19 million compared to VND 17,881.4 million a year ago. Basic earnings per share from continuing operations was VND 2,448 compared to VND 1,975 a year ago.